Flomoxef is an oxacephem antibiotic that was developed by Shionogi.

It has been classified either as a second-generation or fourth-generation cephalosporin.

It was patented in 1982 and approved for medical use in 1988 under the trade name Flumarin.

References



(PDF) Relation between flomoxef minimum inhibitory concentrations and

Table 1 from Comparative effectiveness of flomoxef versus carbapenems

Flomoxef Sodiumsusceptibility testingTOKUE

Therapeutic effects of flomoxef (FMOX) on pyometra in a rat model

FF41634 92823035 Flomoxef Sodium Biosynth